ECANSYA

This brand name is authorized in Austria, Germany, Estonia, Finland, Croatia, Ireland, Lithuania, Poland

Active ingredients

The drug ECANSYA contains one active pharmaceutical ingredient (API):

1 Capecitabine UNII 6804DJ8Z9U - CAPECITABINE

Capecitabine is a non-cytotoxic fluoropyrimidine carbamate, which functions as an orally administered precursor of the cytotoxic moiety 5-fluorouracil (5-FU). There is evidence that the metabolism of 5-FU in the anabolic pathway blocks the methylation reaction of deoxyuridylic acid to thymidylic acid, thereby interfering with the synthesis of deoxyribonucleic acid (DNA). The incorporation of 5-FU also leads to inhibition of RNA and protein synthesis. Read about Capecitabine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ECANSYA Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01BC06	Capecitabine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 10050364, 10050370, 10050424, 10050430, 14062358, 16144824, 16768281
Country: EE	Ravimiamet	Identifier(s): 1568066, 1568077, 1568088, 1568099, 1568101, 1568112, 1568123, 1568134, 1568145
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 123487, 542291
Country: IE	Health Products Regulatory Authority	Identifier(s): 88378, 88379
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1066198, 1066199, 1066200, 1066201, 1066202, 1066203, 1066204, 1066205, 1066206, 1066207, 1066208, 1066209, 1066210, 1066211, 1066212, 1066213, 1066214, 1066215
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100286559, 100286565, 100286588